Related references
Note: Only part of the references are listed.Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
Birgitta Metternich et al.
EPILEPSY & BEHAVIOR (2021)
Two-center experience of cannabidiol use in adults with Dravet syndrome
Katri Silvennoinen et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
White matter integrity after cannabidiol administration for treatment resistant epilepsy
J. T. Houston et al.
EPILEPSY RESEARCH (2021)
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
Anup D. Patel et al.
EPILEPSIA (2021)
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy
Leslie Grayson et al.
EPILEPSY & BEHAVIOR (2021)
Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice
Pabitra Hriday Patra et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Cannabidiol in treatment of refractory epileptic spasms: An open-label study
Aline Herlopian et al.
EPILEPSY & BEHAVIOR (2020)
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy
Matthew D. Thompson et al.
EPILEPSY & BEHAVIOR (2020)
Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy
David E. Anderson et al.
BRAIN COMMUNICATIONS (2020)
Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model
Ester Aso et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy
Rodolphe Nenert et al.
EPILEPSY & BEHAVIOR (2020)
Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsy
Tyler E. Gaston et al.
EPILEPSY & BEHAVIOR (2020)
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy
Alberto Pauletti et al.
BRAIN (2019)
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy
Roy C. Martin et al.
EPILEPSY & BEHAVIOR (2019)
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra et al.
EPILEPSIA (2019)
A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy
Ayushe A. Sharma et al.
EPILEPSY & BEHAVIOR REPORTS (2019)
Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia
David Neubauer et al.
EPILEPSY & BEHAVIOR (2018)
Biphasic effects of THC in memory and cognition
Edward J. Calabrese et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
Amanda J. Sales et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer like symptoms in a transgenic animal model
Ester Aso et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabis for the Treatment of Epilepsy: an Update
Tyler E. Gaston et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
DRUGS (2018)
Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
Evan C. Rosenberg et al.
EPILEPSIA (2017)
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy
Jane B. Allendorfer et al.
EPILEPSY & BEHAVIOR (2017)
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Ashleigh L. Osborne et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders
Jonathan L. C. Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Current Concepts of Memory Disorder in Epilepsy: Edging Towards a Network Account
Genevieve Rayner et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
Michal Tzadok et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Ryan Vandrey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Cannabis, cannabidiol, and epilepsy - From receptors to clinical response
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2014)
The Cognition Battery of the NIH Toolbox for Assessment of Neurological and Behavioral Function: Validation in an Adult Sample
Sandra Weintraub et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2014)
Levetiracetam reduces abnormal network activations in temporal lobe epilepsy
Britta Wandschneider et al.
NEUROLOGY (2014)
Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or Δ9-tetrahydrocannabinol (THC)
Matthijs G. Bossong et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
Albert Batalla et al.
PLOS ONE (2013)
Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2012)
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
Y. Avraham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The effect of seizures on working memory and executive functioning performance
Leah Chapman Black et al.
EPILEPSY & BEHAVIOR (2010)
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
Iddo Magen et al.
JOURNAL OF HEPATOLOGY (2009)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
Erica J. Carrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo
CA Lunn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
EpiTrack: Tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy
MT Lutz et al.
EPILEPSY & BEHAVIOR (2005)
Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity
C Hamelink et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization
C Helmstaedter et al.
EPILEPSY & BEHAVIOR (2004)
Memory and epilepsy: characteristics, course, and influence of drugs and surgery
C Helmstaedter et al.
CURRENT OPINION IN NEUROLOGY (2001)
Share Paper
